[go: up one dir, main page]

GB8913889D0 - New compositions of matter - Google Patents

New compositions of matter

Info

Publication number
GB8913889D0
GB8913889D0 GB898913889A GB8913889A GB8913889D0 GB 8913889 D0 GB8913889 D0 GB 8913889D0 GB 898913889 A GB898913889 A GB 898913889A GB 8913889 A GB8913889 A GB 8913889A GB 8913889 D0 GB8913889 D0 GB 8913889D0
Authority
GB
United Kingdom
Prior art keywords
matter
new compositions
ketoprofen
awater
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898913889A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Priority to GB898913889A priority Critical patent/GB8913889D0/en
Publication of GB8913889D0 publication Critical patent/GB8913889D0/en
Priority to DE69011588T priority patent/DE69011588T2/en
Priority to EP90401648A priority patent/EP0403383B1/en
Priority to DK90401648.2T priority patent/DK0403383T3/en
Priority to ES90401648T priority patent/ES2068353T3/en
Priority to AT90401648T priority patent/ATE109975T1/en
Priority to CA002019108A priority patent/CA2019108A1/en
Priority to JP2156664A priority patent/JPH0363220A/en
Priority to US07/539,193 priority patent/US5188841A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The invention provides a sustained release formulation of ketoprofen comprising granules each of which comprises a core comprising ketoprofen and microcrystalline cellulose and a coating comprising awater-soluble and a water-insoluble cellulose derivative.
GB898913889A 1989-06-16 1989-06-16 New compositions of matter Pending GB8913889D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB898913889A GB8913889D0 (en) 1989-06-16 1989-06-16 New compositions of matter
DE69011588T DE69011588T2 (en) 1989-06-16 1990-06-14 Sustained release pharmaceutical formulations.
EP90401648A EP0403383B1 (en) 1989-06-16 1990-06-14 Sustained release pharmaceutical formulations
DK90401648.2T DK0403383T3 (en) 1989-06-16 1990-06-14 Pharmaceutical depot preparations
ES90401648T ES2068353T3 (en) 1989-06-16 1990-06-14 PHARMACEUTICAL FORMULATIONS OF PROLONGED RELEASE.
AT90401648T ATE109975T1 (en) 1989-06-16 1990-06-14 SUSTAINED RELEASE PHARMACEUTICAL FORMULATIONS.
CA002019108A CA2019108A1 (en) 1989-06-16 1990-06-15 Sustained release pharmaceutical formulations
JP2156664A JPH0363220A (en) 1989-06-16 1990-06-16 Sustained discharging pharmaceutical preparation
US07/539,193 US5188841A (en) 1989-06-16 1990-06-18 Sustained release pharmaceutical formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913889A GB8913889D0 (en) 1989-06-16 1989-06-16 New compositions of matter

Publications (1)

Publication Number Publication Date
GB8913889D0 true GB8913889D0 (en) 1989-08-02

Family

ID=10658565

Family Applications (1)

Application Number Title Priority Date Filing Date
GB898913889A Pending GB8913889D0 (en) 1989-06-16 1989-06-16 New compositions of matter

Country Status (9)

Country Link
US (1) US5188841A (en)
EP (1) EP0403383B1 (en)
JP (1) JPH0363220A (en)
AT (1) ATE109975T1 (en)
CA (1) CA2019108A1 (en)
DE (1) DE69011588T2 (en)
DK (1) DK0403383T3 (en)
ES (1) ES2068353T3 (en)
GB (1) GB8913889D0 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
ES2168043B1 (en) * 1999-09-13 2003-04-01 Esteve Labor Dr PHARMACEUTICAL FORM ORAL SOLID MODIFIED RELEASE CONTAINING A COMPOSITE OF BENCIMIDAZOL LABIL IN THE MIDDLE ACID.
EP1252886A1 (en) * 2001-04-27 2002-10-30 Universiteit Gent Controlled release pharmaceutical pellet compositions
GB0025208D0 (en) * 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
MXPA03006217A (en) * 2001-01-12 2004-10-15 Sun Pharmaceutical Ind Ltd Spaced drug delivery system.
MXPA03008997A (en) * 2001-04-10 2004-02-12 Sun Pharmaceutical Ind Ltd Timed pulse release composition.
ES2427930T3 (en) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Therapeutic composition for the regenerative treatment of cartilage diseases
CN1520313A (en) 2001-05-23 2004-08-11 ������ҩ��ʽ���� A composition for accelerating fracture healing
AR036797A1 (en) 2001-10-15 2004-10-06 Ferring Bv A METHOD TO PREPARE A PHARMACEUTICAL COMPOSITION THAT INCLUDES 5-AMINOSALICILIC ACID TO USE IN THE TREATMENT OF ULCEROSE COLITIS AND CROHN DISEASES
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
FR2842735B1 (en) * 2002-07-26 2006-01-06 Flamel Tech Sa MODIFIED RELEASE MICROCAPSULES OF LOW SOLUBLE ACTIVE PRINCIPLES FOR PER OS ADMINISTRATION
KR100628263B1 (en) * 2002-08-21 2006-09-27 엘지.필립스 엘시디 주식회사 LCD
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
CA2520197A1 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8273371B2 (en) 2003-06-27 2012-09-25 Johan Adriaan Martens Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
GB0315012D0 (en) 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007110753A2 (en) * 2006-03-28 2007-10-04 Wockhardt Ltd Extended release dosage forms of metoprolol
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP1935405A1 (en) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Orally disintegrating tablets
ES2350029T3 (en) * 2007-03-02 2011-01-17 Farnam Companies, Inc. SUSTAINED RELEASE PELLETS THAT INCLUDE A WAX TYPE MATERIAL.
JP5608653B2 (en) * 2008-09-04 2014-10-15 ファーナム・カンパニーズ・インコーポレーテッド Chewable sustained release formulation
CN102813638A (en) * 2011-06-07 2012-12-12 贵阳医学院 Preparation method of dexketoprofen trometamol double-layer sustained-release tablets

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1568837A (en) * 1975-10-10 1980-06-04 Squibb & Sons Inc Controlled release tablet
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
DD146547A5 (en) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim MEDICINAL RETARDANT SHAPE WITH UNFORGETTABLE POROESEN DIFFUSION SHELLS
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
SE457505B (en) * 1984-01-10 1989-01-09 Lejus Medical Ab LAMINATED ORAL PHARMACEUTICAL COMPOSITION AND PROCEDURES FOR ITS PREPARATION
IE861284L (en) * 1986-05-14 1987-11-14 Birex Res And Dev Ltd And Carm Controlled release ketoprofen.
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations

Also Published As

Publication number Publication date
DE69011588D1 (en) 1994-09-22
CA2019108A1 (en) 1990-12-16
JPH0363220A (en) 1991-03-19
DE69011588T2 (en) 1994-12-15
ES2068353T3 (en) 1995-04-16
EP0403383B1 (en) 1994-08-17
DK0403383T3 (en) 1994-09-12
US5188841A (en) 1993-02-23
EP0403383A1 (en) 1990-12-19
ATE109975T1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
GB8913889D0 (en) New compositions of matter
NO308303B1 (en) Water-soluble rapamycin esters, their use, and pharmaceutical composition comprising the compounds
EG19200A (en) Coated perfume particles.
AU8907291A (en) Plant extracts as mucosal-protective agents
CA2116115A1 (en) Sustained-release matrices for dental application
AU8131191A (en) Sustained release formulations
AU2178392A (en) Albuterol sulfate suspension aerosol formulations
KR19987002466A (en) Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
MY136231A (en) Slow release compositions
IL117595A0 (en) Naphthylacetic acid derivatives and their use as pesticides
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
AU6367890A (en) Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same
PL327567A1 (en) Prolonged release granules containing dilthiazem as their active ingredient
AU1752195A (en) Endovascular hepatic prostheses
GB2269384B (en) Amphoteric surfactants-containing wax compositions, their production and their use
AU3782397A (en) Slow release formulations of pesticides
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AU1521192A (en) Aqueous coating compositions
HUT55958A (en) Herbicide compositions and process for the extirpation of non-wanted plants
IL117629A (en) Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof
IL116826A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116747A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL118002A (en) Insecticide formulations and process for the manufacture thereof
AU1845592A (en) Acetanilides